Overview

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Status:
COMPLETED
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Comparative study of the pharmacodynamic parameters and pharmacodynamic equivalence (bioequivalence) of drug Antareit 800 mg chewable tablets and drug Riopan 800 mg chewable tablets in healthy volunteers.
Phase:
NA
Details
Lead Sponsor:
Valenta Pharm JSC
Treatments:
magaldrate